M J Rybak Selected Research

M J Rybak Research Topics

17	Infections 11/2019 - 03/2000
4	Endocarditis 01/2017 - 07/2000
2	Soft Tissue Infections 03/2006 - 03/2001
2	Body Weight (Weight, Body) 11/2000 - 07/2000
1	Coinfection 01/2017
1	Gram-Positive Bacterial Infections 03/2006
1	Communicable Diseases (Infectious Diseases) 04/2001
1	Bacteremia 02/2001
1	Bacterial Endocarditis 07/2000

7	Daptomycin FDA Link 01/2017 - 07/2000
6	Vancomycin FDA LinkGeneric 11/2019 - 07/2000
5	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017 - 07/2000
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2006 - 07/2000
3	AminoglycosidesIBA 04/2001 - 07/2000
2	Linezolid (Zyvox)FDA Link 12/2001 - 03/2001
2	oritavancinIBA 12/2001 - 11/2000
2	Levofloxacin (Levaquin)FDA Link 08/2001 - 03/2000
2	Penicillins (Penicillin)FDA Link 04/2001 - 03/2000
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 02/2001 - 05/2000
2	GlycopeptidesIBA 11/2000 - 07/2000
2	FibrinIBA 07/2000 - 03/2000
2	trovafloxacinIBA 05/2000 - 03/2000
1	Ceftaroline FDA Link 11/2019
1	alpha,beta-diacryloxypropionic acid (DAPS)IBA 01/2017
1	LipopeptidesIBA 03/2006
1	FluoroquinolonesIBA 08/2001
1	Pharmaceutical PreparationsIBA 04/2001
1	Methicillin (Metin)FDA Link 04/2001
1	beta-LactamsIBA 04/2001
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 02/2001
1	triphenylmethylphosphoniumIBA 08/2000
1	Proteins (Proteins, Gene)FDA Link 08/2000
1	arbekacinIBA 07/2000
1	Anti-Infective Agents (Microbicides)IBA 07/2000
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2000
1	CreatinineIBA 05/2000
1	sparfloxacin (AT 4140)FDA Link 03/2000
1	Gatifloxacin (Zymar)FDA Link 03/2000
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2000
1	clinafloxacinIBA 03/2000